Virology News and Research

Latest Virology News and Research

Imaxio awarded ANR funding to improve efficacy of vaccines for seasonal influenza

Imaxio, a biopharmaceutical company specialized in vaccines, today announces that it has been awarded funding of EUR 600,000 (USD 772,000) by the French National Research Agency (Agence Nationale de la Recherche, ANR) for the OPTIVAC project 'leveraging On t-cell immune resPonse To Improve influenza VACcines'.

28 Oct 2014

Cleaver Scientific helps in UK fight against Ebola

Cleaver Scientific reports that its horizontal electrophoresis equipment is being used on the frontline of the UK fight against Ebola.

From Cleaver Scientific Ltd 27 Oct 2014

Johns Hopkins to lead, design interactive Web-based Ebola training program

Johns Hopkins Medicine has been tasked by the Centers for Disease Control and Prevention to lead a group and to design an interactive Web-based learning program that guides health care workers, nurses and physicians through government-approved protocols to aid clinicians as they provide care to patients who may be at risk of contracting the Ebola virus.

27 Oct 2014

Salk Institute scientists identify promising target for HIV/AIDS treatment

Like a slumbering dragon, HIV can lay dormant in a person's cells for years, evading medical treatments only to wake up and strike at a later time, quickly replicating itself and destroying the immune system.

27 Oct 2014

Rewriting the family history of Ebola

The research shows that filoviruses — a family to which Ebola and its similarly lethal relative, Marburg, belong — are at least 16-23 million years old.

27 Oct 2014

Tiny nano-sized particles may play major role in detecting, tracking breast cancer

Exosomes, tiny, virus-sized particles released by cancer cells, can bioengineer micro-RNA (miRNA) molecules resulting in tumor growth. They do so with the help of proteins, such as one named Dicer. New research from The University of Texas MD Anderson Cancer Center suggests Dicer may also serve as a biomarker for breast cancer and possibly open up new avenues for diagnosis and treatment.

27 Oct 2014

Researchers to explore new treatment strategies using blood plasma from Ebola survivors

The University of Liverpool is part of an international research team that will assess whether the blood or plasma of Ebola survivors can be used to treat Ebola patients in West Africa.

27 Oct 2014

US hospitals lack infection prevention staff, resources to fight Ebola

Only 6 percent of U.S. hospitals are well-prepared to receive a patient with the Ebola virus, according to a survey of infection prevention experts at U.S. hospitals conducted October 10-15 by the Association for Professionals in Infection Control and Epidemiology (APIC).

24 Oct 2014

Longer looks: Obamacare in the midterm campaign; watching Ebola mutate; lessons on dying

According to Kantar Media, a firm that tracks political advertising, health care is the main subject of campaign ads, especially Republican ones. Obamacare is unpopular-;over half of Americans disapprove of it. Republicans talk about it constantly on the campaign trail, though not as intemperately as they did during their own party's primaries. Democrats scarcely mention it (10/18).

24 Oct 2014

Aseptika launches Contactless Thermometer and Pulse Oximeter

With the winter flu and cold season almost upon us we can stock up and take some steps to prepare at home for this eventuality. Having a flu jab, eating well, getting lots of exercise and sleep, and maintain good personal hygiene all help in preventing flu and colds.

23 Oct 2014

Passengers from West Africa to start 3-week Ebola screening

The Centers for Disease Control and Prevention has announced that any person flying into the USA from Liberia, Sierra Leone or Guinea will soon have to undergo daily Ebola monitoring for several weeks after their arrival.

23 Oct 2014

Public worries about Ebola increase faster than cases

A Pew Research Center survey finds 41 percent of Americans say they worry they or someone in their families will be "exposed" to the Ebola virus, up from 32 percent two weeks ago. Public confidence in the government's ability to combat the disease has also dropped, finds a Gallup poll. Meanwhile, GOP doctors in the House of Representatives seek a temporary travel ban for West African countries affected by Ebola.

23 Oct 2014

Human trial of second investigational Ebola vaccine candidate under way

Human testing of a second investigational Ebola vaccine candidate is under way at the National Institutes of Health's Clinical Center in Bethesda, Maryland.

23 Oct 2014

Helping children understand Ebola

It dominates the headlines and is striking fear and panic in many communities around the world, Ebola. The constant barrage of information and so much unknown can be especially difficult for children, making it all the more important for parents to help their kids feel safe and to have a dialogue with them at the appropriate developmental level.

23 Oct 2014

ADI develops ELISA test kits for detection of Ebola viral protein antibodies

San Antonio, Texas-based Biotech Company Alpha Diagnostic Int'l has developed and released several convenient, rapid, and sensitive ELISA test kits for the detection of major Ebola viral protein antibodies (Glycoprotein, GP; Nucleoprotein, NP, and Viral Protein 40 or VP40).

23 Oct 2014

Regulus Therapeutics demonstrates human proof-of-concept with microRNA therapeutic

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has demonstrated human proof-of-concept with a microRNA therapeutic from an ongoing clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 (“miR-122”), for the treatment of hepatitis C virus infection (“HCV”).

22 Oct 2014

Hospitals demand TRU-D SmartUVC device to be added to Ebola protocols

Following the tragic infections of two hospital staff and subsequent tracking of hundreds of people related to Ebola, hospitals around the country are requiring TRU-D SmartUVC, a portable automated UVC disinfection robot which accurately measures required dosage, be added to Ebola protocols.

21 Oct 2014